Healthcare Services Group, Inc. (HCSG) P/E Ratio History
Historical price-to-earnings valuation from 1990 to 2025
Loading P/E history...
HCSG Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Healthcare Services Group, Inc. (HCSG) trades at a price-to-earnings ratio of 26.8x, with a stock price of $21.73 and trailing twelve-month earnings per share of $0.82.
The current P/E is 14% below its 5-year average of 31.4x. Over the past five years, HCSG's P/E has ranged from a low of 16.5x to a high of 107.4x, placing the current valuation at the 60th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, HCSG trades at a 21% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 171.0x.
Relative to the broader market, HCSG trades roughly in line with the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HCSG DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HCSG P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $559M | 12.0Lowest | - | -15% | |
| $2B | 15.7 | 0.05Best | +102%Best | |
| $68B | 38.5 | 2.30 | +16% | |
| $2B | 13.4 | - | -8% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
HCSG Historical P/E Data (1990–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $19.12 | $0.81 | 23.6x | -17% |
| FY2025 Q3 | $16.83 | $0.53 | 31.8x | +11% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $15.03 | $0.14 | 107.4x | +276% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $10.08 | $0.56 | 18.1x | -36% |
| FY2024 Q4 | $11.62 | $0.53 | 22.1x | -23% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $11.17 | $0.68 | 16.5x | -42% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $10.58 | $0.41 | 25.7x | -10% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $12.48 | $0.56 | 22.4x | -21% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $10.37 | $0.52 | 20.1x | -30% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $10.43 | $0.43 | 24.5x | -14% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $14.93 | $0.50 | 29.6x | +4% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $13.87 | $0.48 | 29.1x | +2% |
Average P/E for displayed period: 28.6x
See HCSG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HCSG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HCSG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHCSG — Frequently Asked Questions
Quick answers to the most common questions about buying HCSG stock.
Is HCSG stock overvalued or undervalued?
HCSG trades at 26.8x P/E, near its 5-year average of 31.4x. The 60th percentile ranking places valuation within normal historical bounds.
How does HCSG's valuation compare to peers?
Healthcare Services Group, Inc. P/E of 26.8x compares to sector median of 22.2x. The premium reflects expected growth above peers.
What is HCSG's PEG ratio?
HCSG PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1990-2025.